These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36238580)

  • 1. Temporal trend of drug-resistant tuberculosis among Thai children during 2006-2021.
    Jantarabenjakul W; Supradish Na Ayudhya P; Suntarattiwong P; Thepnarong N; Rotcheewaphan S; Udomsantisuk N; Moonwong J; Kosulvit P; Tawan M; Sudjaritruk T; Puthanakit T
    IJID Reg; 2022 Dec; 5():79-85. PubMed ID: 36238580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Drug-Resistant Tuberculosis in Children in Shenyang, China, 2017-2021.
    Sun J; Fan L; Zhao Y; Wu H; Li R; Tian Y; Cheng M; Ma X; Ma Y; Yang X; Shen A; Yu Y; Chen Y
    Infect Drug Resist; 2023; 16():6983-6998. PubMed ID: 37933293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
    PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy.
    Chhajed PN; Vaidya PJ; Mandovra NP; Chavhan VB; Lele TT; Nair R; Leuppi JD; Saha A
    ERJ Open Res; 2019 Oct; 5(4):. PubMed ID: 31754620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
    Shah I; Shah F
    Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era.
    Utpat KV; Rajpurohit R; Desai U
    Lung India; 2023; 40(1):19-23. PubMed ID: 36695254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    Chiang TY; Fan SY; Jou R
    PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory.
    Podlekareva DN; Folkvardsen DB; Skrahina A; Vassilenko A; Skrahin A; Hurevich H; Klimuk D; Karpov I; Lundgren JD; Kirk O; Lillebaek T
    Tuberc Res Treat; 2021; 2021():6646239. PubMed ID: 33868727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
    Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
    Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
    Barilar I; Fernando T; Utpatel C; Abujate C; Madeira CM; José B; Mutaquiha C; Kranzer K; Niemann T; Ismael N; de Araujo L; Wirth T; Niemann S; Viegas S
    Lancet Infect Dis; 2024 Mar; 24(3):297-307. PubMed ID: 37956677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis diagnosis since Xpert
    Lavu EK; Johnson K; Banamu J; Pandey S; Carter R; Coulter C; Aia P; Majumdar SS; Marais BJ; Graham SM; Vince J
    Public Health Action; 2019 Sep; 9(Suppl 1):S12-S18. PubMed ID: 31579644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
    Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
    Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of chemotherapy for tuberculosis in national tuberculosis programmes of low- and middle-income countries.
    Chiang CY; Lin CJ
    Indian J Tuberc; 2020 Dec; 67(4S):S16-S22. PubMed ID: 33308663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis.
    Lin M; Chen YW; Li YR; Long LJ; Qi LY; Cui TT; Wu SY; Lin JY; Wu T; Yang YC; Yuan WH; Wu GY; Lan QW; Liu JQ; Li YP; Yu ZY; Guo XG
    Clin Chim Acta; 2022 Aug; 533():183-218. PubMed ID: 35792161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-extensively drug-resistant tuberculosis among pulmonary multidrug-resistant tuberculosis patients in Eastern Nigeria.
    Nwachukwu NO; Ulasi AE; Okoronkwo CU; Unegbu VN
    Lung India; 2023; 40(6):492-495. PubMed ID: 37961955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.